Acinetobacter baumannii and Acinetobacter genospecies 13tu and 3 bacteraemia: Comparison of clinical features, prognostic factors and outcomes

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 8, 2011, Pages 1839-1846

  Lee, Yi Chieh ^a   Huang, Yu Tsung ^a   Tan, Che Kim ^b   Kuo, Yao Wen ^a   Liao, Chun Hsing ^c   Lee, Ping Ing ^a   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

16S 23S rRNA gene; Acinetobacter genospecies 13TU; Acinetobacter genospecies 3; Bacteraemia; Mortality; Multidrug resistance

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE; TIMENTIN;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CENTRAL VENOUS CATHETER; CEREBROVASCULAR ACCIDENT; CHRONIC LUNG DISEASE; CLONAL VARIATION; COMORBIDITY; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENOTYPE; HEART INFARCTION; HEMIPLEGIA; HUMAN; KIDNEY DISEASE; LENGTH OF STAY; LEUKEMIA; LIVER DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; PEPTIC ULCER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; URINARY TRACT INFECTION; WOUND;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR TYPING; PROGNOSIS; TREATMENT OUTCOME;

EID: 79960442289     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr200     Document Type: Article

References (34)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-82.
2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-51.
3. Ko WC, Lee NY, Su SC et al. Oligunucleotide-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J Clin Microbiol 2008; 46: 2052-9.
4. Lin YC, Sheng WH, Chang SC et al. Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities. J Clin Microbiol 2008; 46: 612-7.
5. Dijkshoorn L, Van Harsselaar B, Tjernberg I et al. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst Appl Microbiol 1998; 21: 33-9.
6. Janssen P, Maquelin K, Coopman R et al. Discrimination of Acinetobacter genomic species by AFLP fingerprinting. Int J Syst Bacteriol 1997; 47: 1179-87.
7. Gerner-Smidt P. Ribotyping of the Acinetobacter calcoaceticus- Acinetobacter baumannii complex. J Clin Microbiol 1992; 30: 2680-5.
8. Ehrenstein B, Bernards AT, Dijkshoorn L et al. Acinetobacter species identification by using tRNA spacer fingerprinting. J Clin Microbiol 1996; 34: 2414-20.
9. Dolzani L, Tonin E, Lagatolla C et al. Identification of Acinetobacter isolates in the A. calcoaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic spacer sequences. J Clin Microbiol 1995; 33: 1108-13.
10. Chang HC, Wei YF, Dijkshoorn L et al. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005; 43: 1632-9.
11. La Scola B, Gundi VA, Khamis A et al. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006; 44: 827-32.
12. Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
13. Jones RN, Ferraro MJ, Reller LB et al. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007; 45: 227-30.
14. Seifert H, Dolzani L, Bressan R et al. Standardization and interlaboratory reproducibility assessment of pulse-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-35.
15. Zarrilli R, Casillo R, Di Popolo A et al. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clin Microbiol Infect 2007; 13: 481-9.
16. Fillaux J, Dubouix A, Conil JM et al. Retrospective analysis of multidrug-resistant Acinetobacter baumannii strains isolated during a 4-year period in a university hospital. Infect Control Hosp Epidemiol 2006; 27: 647-53.
17. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-83.
18. Paterson DL, Ko WC, Von Gottberg A et al. International prospective study of Klebsiella pneumoniae bacteraemia: implications of extended-spectrum b-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 26-32.
19. Garner JS, Jaris WR, Emori TG et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-40.
20. Lee NY, Chang TC, Wu CJ et al. Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteraemia. J Infect 2010; 61: 219-27.
21. Chuang YC, Sheng WH, Li SY et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteraemia. Clin Infect Dis 2011; 52: 352-60.
22. Lee NY, Lee HC, Ko NY et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteraemia. Infect Control Hosp Epidemiol 2007; 28: 713-9.
23. Seifert H, Baginski R, Schulze A et al. Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother 1993; 37: 750-3.
24. Go ES, Urban C, Burns J et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344: 1329-32.
25. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteraemia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003; 29: 471-5.
26. Grupper M, Sprecher H, Mashiach T et al. Attributable mortality of nosocomial Acinetobacter bacteraemia. Infect Control Hosp Epidemiol 2007; 28: 293-8.
27. Wisplinghoff H, Perbix W, Seifert H. Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients. Clin Infect Dis 1999; 28: 59-66.
28. Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
29. McDonald A, Amyes SG, Paton R. The persistence and clonal spread of a single strain of Acinetobacter 13TU in a large Scottish teaching hospital. J Chemother 1999; 11: 338-44.
30. Lee JH, Choi CH, Kang HY et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Antimicrob Chemother 2007; 59: 633-9.
31. Kuo LC, Teng LJ, Yu CJ et al. Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J Clin Microbiol 2004; 42: 1759-63.
32. Hsueh PR, Teng LJ, Chen CY et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 2002; 8: 827-32.
33. Park YK, Jung SI, Park KH et al. Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol Infect Dis 2009; 64: 43-51.
34. Adams MD, Nickel GC, Bajaksouzian S et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009; 53: 3628-34.